[HTML][HTML] A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum

N Beutler, T Pholcharee, D Oyen… - PLoS …, 2022 - journals.plos.org
Potent and durable vaccine responses will be required for control of malaria caused by
Plasmodium falciparum (Pf). RTS, S/AS01 is the first, and to date, the only vaccine that has …

A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum

N Beutler, T Pholcharee, D Oyen… - PLoS …, 2022 - pubmed.ncbi.nlm.nih.gov
Potent and durable vaccine responses will be required for control of malaria caused by
Plasmodium falciparum (Pf). RTS, S/AS01 is the first, and to date, the only vaccine that has …

A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum.

N Beutler, T Pholcharee, D Oyen, Y Flores-Garcia… - 2022 - cabidigitallibrary.org
Potent and durable vaccine responses will be required for control of malaria caused by
Plasmodium falciparum (Pf). RTS, S/AS01 is the first, and to date, the only vaccine that has …

A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum

T Pholcharee, M Parren, JA Regules, S Dutta… - PLoS …, 2022 - search.proquest.com
Potent and durable vaccine responses will be required for control of malaria caused by
Plasmodium falciparum (Pf). RTS, S/AS01 is the first, and to date, the only vaccine that has …

[PDF][PDF] A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum

N Beutler, T Pholcharee, D Oyen, Y Flores-Garcia… - PLoS Pathog, 2022 - academia.edu
Potent and durable vaccine responses will be required for control of malaria caused by
Plasmodium falciparum (Pf). RTS, S/AS01 is the first, and to date, the only vaccine that has …

A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum.

N Beutler, T Pholcharee, D Oyen, Y Flores-Garcia… - Plos …, 2022 - europepmc.org
Potent and durable vaccine responses will be required for control of malaria caused by
Plasmodium falciparum (Pf). RTS, S/AS01 is the first, and to date, the only vaccine that has …

A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum.

N Beutler, T Pholcharee, D Oyen… - PLoS …, 2022 - search.ebscohost.com
Potent and durable vaccine responses will be required for control of malaria caused by
Plasmodium falciparum (Pf). RTS, S/AS01 is the first, and to date, the only vaccine that has …

A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum.

N Beutler, T Pholcharee, D Oyen, Y Flores-Garcia… - PLoS …, 2022 - go.gale.com
Potent and durable vaccine responses will be required for control of malaria caused by
Plasmodium falciparum (Pf). RTS, S/AS01 is the first, and to date, the only vaccine that has …

A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum

N Beutler, T Pholcharee, D Oyen, Y Flores-Garcia… - PLOS Pathogens, 2022 - cir.nii.ac.jp
抄録< jats: p> Potent and durable vaccine responses will be required for control of malaria
caused by< jats: italic> Plasmodium falciparum (Pf)</jats: italic>. RTS, S/AS01 is the first …

A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum.

N Beutler, T Pholcharee, D Oyen… - PLoS …, 2022 - escholarship.org
Potent and durable vaccine responses will be required for control of malaria caused by
Plasmodium falciparum (Pf). RTS, S/AS01 is the first, and to date, the only vaccine that has …